Filter
120
Text search:
antibiotic
stewardship
Featured
Recommendations
12
New Publications
24
Language
Document type
Studies & Reports
50
Guidelines
25
No document type
15
Strategic & Response Plan
12
Manuals
5
Fact sheets
5
Online Courses
3
Resource Platforms
2
Training Material
1
Dashboards/Maps
1
Situation Updates
1
Countries / Regions
South Africa
8
Kenya
4
Ethiopia
3
Malawi
3
Philippines
2
India
2
Latin America and the Carribbean
2
Western and Central Europe
2
Africa
2
Global
2
Nigeria
1
Senegal
1
Mali
1
Ghana
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Germany
1
Lebanon
1
Tanzania
1
Thailand
1
Bangladesh
1
Sudan
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Bhutan
1
Eastern Europe
1
Iran
1
Gabon
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
24
Clinical Guidelines
3
Women & Child Health
2
Key Resources
2
Capacity Building
1
Public Health
1
Pharmacy & Technologies
1
Toolboxes
AMR
96
TB
6
Global Health Education
4
Pharmacy
4
Caregiver
3
Planetary Health
3
Rapid Response
2
2.0 Rapid Response
2
Cholera
1
Polio
1
COVID-19
1
NTDs
1
NCDs
1
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
Ending Cholera. A global roadmap to 2030
recommended
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health
Manual for Early Implementation
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou
...
Health care-associated infections (HAIs) affect patients and health systems every day, causing immense suffering, driving higher health-care costs and hampering efforts to achieve high-quality care for all. HAIs are often difficult to treat, are the major driver of antimicrobial resistance (AMR) and
...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
The power relations around global decisions which shape population health can be changed through new alliances and information flows. The Democratising Global Health Governance Initiative, of which WHO Watch is a project, is designed to contribute to improved population health (and health equity) th
...
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d
...
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description of practices, how they were implemented, achievements, and why the practice was unique.
